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Abstract
Scavenger receptor (ScR)-mediated uptake ofmodified lipo-
proteins may contribute to the transformation of smooth
muscle cells into lipid-laden foam cells during atherogenesis.
This study examined theinvivoexpression ofScRsin aortas,
with or without balloon injury, taken from hypercholester-
olemic or normocholesterolemic rabbits. Numerous intimal
cells in the rabbit aortic lesions expressed ScRs as detected
by immunocytochemical staining with a goat anti-rabbit
ScR antibody. Single immunostaining for cell identification
markers in serial sections, as well as double staining, con-
firmed the expression of ScRs by both intimal smooth mus-
cle cells and macrophages. To explore potential inducers of
ScR expression by smooth muscle cells in vivo, we studied
the regulation ofScRexpression in vitro by cytokines known
to be present in atherosclerotic lesions. Tumor necrosis fac-
tor-a (TNF-a) or interferon-y (IFN-y) increased ScR
mRNA levels, protein expression, and AcLDL degradative
activity in cultured rabbit aortic smooth muscle cells. The
induction of ScR expression in intimal smooth muscle cells
in vivo could be a useful marker of smooth muscle cell
activation during atherogenesis and may contribute to foam
cell formation by this cell type following balloon injury and/
or hypercholesterolemia. Cytokines, such as TNF-a or
IFN-y, may stimulate some of the phenotypic changes that
characterize the alteration in gene expression of intimal
smooth muscle cells in rabbitatherosclerotic lesions. (J. Clin.
Invest. 1995. 95:122-133.) Key words: scavenger receptor -
smooth muscle cells * atherosclerosis * rabbit * balloon
injury
Introduction
The accumulation of lipid-laden foam cells, derived from mac-
rophages and smooth muscle cells, is one of the characteristic
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early changes in the arterial intima of a developing atheroscle-
rotic plaque (1-4). Although a detailed understanding of the
process leading to the transformation of macrophages and
smooth muscle cells into foam cells is notavailable, this process
appears to involve receptor-mediated uptake ofcholesterol-rich
particles (1, 5). As thebindingofnative low density lipoproteins
(LDL) to the LDL receptor in vitro does not result in foam cell
formation, alternative receptorpathways were soughtto account
for this phenomenon (6). The identification of a new type of
lipoprotein receptor, the acetyl-LDL or scavenger receptor
(ScR),' provided a candidate protein whose activity could medi-
ate the formation of foam cells (5, 7).
Scavenger receptors are integral membrane proteins that
bind and internalize a broad array of ligands, including ace-
tylated and oxidized LDL. Unlike the LDL receptor, their activ-
ity is not suppressed by rising intracellular cholesterol concen-
trations, thus providing a mechanism for massive cholesterol
uptake. Nonmacrophage cells transfected withcDNAs encoding
scavenger receptors accumulate cholesterol and develop a foam
cell appearance when incubated with modified LDL, whereas
mock-transfected cells do not (8). These findings suggested that
the expression of scavenger receptor protein might be both nec-
essary and sufficient to account for foam cell formation in vivo.
ScR cDNAs have now been cloned from bovine, human,
murine, and rabbit sources (9-13). Two cDNAs, encoding a
type I receptor and a shorter type H receptor, have been identi-
fied in all four species. Both type I and type II receptors are
glycoproteins that bind their ligands (e.g., AcLDL) with high
affinity, apparently via acollagen-like domain in the extracellu-
lar carboxyl-terminal portion of the molecule (14, 15). Both
receptors have been found in macrophage cell lines and macro-
phage-rich tissues, including atherosclerotic plaques (16-18).
The immunohistochemical demonstration of ScR expression in
macrophage-derived foam cells at various stages of atheroscle-
rosis strengthens the evidence that they contribute to the trans-
formation ofmacrophages into foam cells during atherogenesis.
During atherogenesis, certain subpopulations of smooth
muscle cells undergo structural and functional changes, one
consequence of which can be their transformation into foam
cells. These altered intimal smooth muscle cells display pheno-
typic features not seen in normal medial smooth muscle cells
(19, 20). Earlier studies have reported the expression of scaven-
ger receptor activity in smooth muscle cells isolated from ath-
erosclerotic lesions ofrabbitaorta, whereas medial smooth mus-
cle cells did not express this activity (21, 22). While the regula-
tion of ScR expression in macrophages by factors thought to
be present in the atherogenic process has been the object of
1. Abbreviation used in this paper: ScR, scavenger receptor.
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this same process in smooth muscle cells. Two recent studies
showed that cultured medial smooth muscle cells ofrabbit aorta
inducibly express macrophage ScR mRNA following stimula-
tion with phorbol esters (13, 27). These observations suggest
that phenotypic modulation or activation of smooth muscle cells
may induce ScR expression as part of a more general program
of altered gene expression. Such alteration in gene expression,
that distinguishes the intimal from medial smooth muscle cell,
may contribute both to the formation of smooth muscle cell-
derived foam cells in atherosclerotic lesions and to the subse-
quent development of complex, fibrotic plaques.
The present study presents evidence that a subpopulation of
intimal smooth muscle cells in rabbit atherosclerotic lesions
express the ScR in vivo, whereas smooth muscle cells in the
adjacent arterial media do not. This work also demonstrates that
cytokines TNF-a and IFN-y, both ofwhich are produced locally
in atherosclerotic lesions, can increase the expression of ScRs
by rabbit vascular smooth muscle cells in vitro.
Methods
Animals. 10 Male New Zealand white, Pasteurella-free rabbits (Mill-
brook Farms, Amherst, MA), weighing FF7E3 kg were used throughout
the study. The rabbits were housed in individual cages. Diet and water
were provided ad libitum. Five rabbits consumed a normal rabbit chow
diet while the other five consumed a hypercholesterolemic chow diet
that contained 0.5% cholesterol and 4.5% hydrogenated coconut oil. At
the end of the sixth week on the diets, the animals were anesthetized
with ketamine (35 mg/kg) and xylazine (7 mg/kg) by intramuscular
injection. Balloon injury to the abdominal aortas was performed as
previously described using aFogarty 3Fballoon catheter (Baxter Hospi-
tal Supply, Edison, NJ) (28). 10 d after balloon injury, the rabbits were
killed and the aortas were removed. Segments from the injured area of
the abdominal aorta and a portion of the thoracic aorta in the uninjured
area were snap-frozen in isopentane, cooled in liquid nitrogen.
Isolation, characterization, and culture ofrabbit aortic smooth mus-
cle cells. Rabbit aortic smooth muscle cells were isolated using an
explant technique as described previously (29, 30). Briefly, cells were
cultured in Dulbecco's Modified Eagle's Medium with 10% fetal bovine
serum, 100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-
glutamine. At confluence, cells were passaged with 0.2% trypsin and
were used between passages 2 and 5 (FF7EI wk/passage). All compo-
nents used in tissue culture media were tested for endotoxin contamina-
tion using the chromogenic Limulus amebocyte lysate assay (Biopro-
ducts, Walkersville, MD) and yielded a final concentration ofendotoxin
less than 40 pg/ml.
Antibodies and reagents. Goat anti-serum recognizing both the type
I and type II rabbit scavenger receptors was raised by injection of a
synthetic peptide of 17 amino acids, corresponding to the sequence of
the NH2-terminal domain of the rabbit ScR, coupled to keyhole limpet
hemocyanin. The sequence of the synthetic peptide was MAQWDSFT-
DQQEDTDSC (kindly synthesized by the Endocrine Unit Peptide Core,
Massachusetts General Hospital). Other antibodies used in this study
include monoclonal antibody (mAb) HHF35 (mouse IgGl; Enzo Diag-
nostic, Inc., New York, NY), which recognizes smooth muscle a-actin
(31), mAb RAM-l1 (mouse IgGl, provided by Dr. Gown, University
ofWashington, Seattle, WA) which recognizes an uncharacterized cyto-
plasmic antigen protein of rabbit macrophages (32), and mAb Ll1/135
(mouse IgGl) which recognizes a 120-kD glycoprotein determinant
present on rabbit thymocytes and peripheral T cells (American Type
Culture Collection, Rockville, MD). Rabbitrecombinantinterleukin (IL)
1-a (Glaxo, England), rabbit recombinant tumor necrosis factor (TNF)-
a (Scripps Clinic and Research Foundation, San Diego, CA), rabbit
recombinant interferon (IFN)-y (Genentech, San Francisco, CA), and
lipopolysaccharide (LPS) (Escherichia coli, 055:B5, Sigma Chemical
Co., St. Louis, MO) were used in the tissue culture studies.
Western blotting. cDNAs encoding the bovine or the rabbit type II
receptor, with or without a rhodopsin epitope tag (33), were transfected
into COS cells in the expression vector pCDNA-1 as previously de-
scribed (13). Mock-transfected COS cells were transfected with
pCDNA-1, containing no inserted DNA. 48 h after transfection, cells
in 100-mm dishes were lysed in either 0.63 or 1.26 ml of lysis buffer
(phosphate buffered saline, 1% Triton X-100, 1 mM PMSF and 0.1 mM
leupeptin). COS cell lysates were subjected to electrophoresis on a 4%
stacking/8% separating SDS polyacrylamide gel in a Bio-Rad mini-
Protean II apparatus (Bio Rad Laboratories, Richmond, CA). Rabbit
ScR/human IgG fusion proteins, lacking the amino acids comprising
the peptide used to raise the goat anti-serum but containing all the other
extracellular domains of the rabbit ScR, were prepared in COS cells,
purified by protein A affinity chromatography, and electrophoresed
along with the cell lysates. These proteins served as additional negative
(anti-ScR antibody) andpositive (ID4antibody) controls fortheWestern
blot procedure. Electrophoretic transfer to nitrocellulose was accom-
plished at 140 V for 3 h at40C in 25 mM Tris, pH 8.3, 192 mM glycine,
and 20% methanol. The membrane was then blocked with 1% Tween-
20 and 10% dried milk in PBS (buffer A) for 1 h at room temperature
(RT). Goat anti-serum against rabbit ScR, diluted 1/100, was added to
fresh Buffer A and incubated for 30 min at RT followed by four washes
in Buffer A without milk. A rabbit anti-goat horseradish peroxidase
(HPO) labeled antibody (Sigma A5420) was then bound in Buffer A
for 30 min at RT followed by four washes as above. Detection of the
peroxidase activity was carried out with 3,3'-diaminobenzidine tetrahy-
drochloride according to the manufacturer's instructions (Sigma Chemi-
cal Co.). The same blotting procedure was conducted using ID4, a
monoclonal antibody recognizing the rhodopsin epitope tag (33), substi-
tuted forthe goat anti-serum, with detection accomplished using arabbit
anti-mouse HPO-labeled second antibody.
Immunohistochemical staining. Immunohistochemical staining was
performed as previously described (34, 35). Briefly, 6-mm-thick frozen
sections from balloon injured or non-injured areas ofrabbit aortas were
adhered to poly-L-Lysine-coated slides, fixed in cold acetone and incu-
bated with antibodies anti-ScR (1/3,000), HHF-35 (1/10), or RAM-il
(1/3,000) for 1 h. After washing three times in Tris-buffered saline (145
mM NaCI and 5 mM Tris, pH 7.4) containing 2% horse serum, species-
appropriate biotinylated secondary antibodies were applied, followed
by avidin-biotin peroxidase complexes (ABC Elite kit; Vector Labs,
Burlingame, CA). Antibody binding was visualized with 3-amino-9-
ethylcarbazole (Sigma Chemical Co.). Sections were counter stained
with Gill's hematoxylin. The same method was used to stain rabbit
aortic smoothmusclecellscultured ineight-chambertissuecultureslides
with or without cytokine stimulation. To evaluate the specificity of the
staining, rabbit smooth muscle cells treated with phorbol ester (100 nm,
24 h), a known inducer of ScR expression in smooth muscle cells (13),
were used as positive controls and omission of primary antibodies and
staining with type- and class-matched nonimmune IgGs were used as
negative controls for each antibody used in this study.
Double immunostaining. To confirm the expression of the ScR by
intimal smooth muscle cells of the rabbit aorta, we performed double
immunostaining onfrozen sections. Afterstaining forthe smooth muscle
cell marker a-actin using the ABC peroxidase method as described
above (yielding a red peroxidase reaction product), sections were
washed in PBS for 5 min followed by 30 min ofincubation with avidin-
biotin blocking compound (Avidin-Biotin blocking kit; Vector Labora-
tories). The second primary antibody (goat anti-rabbit ScR) was then
applied at 1/2,000 dilution andincubated at4°C overnight. Afterincuba-
tion with biotinylated horse anti-goat antibody, sections were then incu-
bated with alkaline phosphatase avidin-biotin complex (Vecstatin ABC
kit, AK-5000; Vector Laboratories) and visualized using Fast Blue
(Sigma Chemical Co.), an alkaline phosphate substrate that produces a
blue product. Double-stained cells showed mixtures of red (SMC) and
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sections.
Northern blot analysis. Northern blot analysis was performed using
standard techniques (36). Total cellularRNA was isolated by centrifuga-
tion through a cesium chloride gradient after lysing the cells with 4 M
guanidinium isothiocyanate. Equal amounts of RNA were electropho-
resed on 1% agarose gels and transferred to nylon membranes (Hybond-
N; Amersham Corp., Arlington Heights, IL). The blots were hybridized
at 420C overnight using a fragment of rabbit ScR cDNA (common to
both type I and type II receptors) which was radiolabeled with 32P by
random-priming (Pharmacia Inc., Piscataway, NJ). The membrane was
washed three times in 2X SSC and 0.1% SDS at 500C for 30 min and
the blots were visualized by autoradiography. The signals on x-ray film
were analyzed by densitometry using the National Institutes of Health
IMAGE program version 1.49.
ScR degradative activity assays. The ability of smooth muscle cells
to degrade 125I- AcLDL (5 jig/ml) over 5 h at 370C in the presence or
absence of unlabeled competitors (native LDL or AcLDL, both at 400
tsg/ml) was assayed as described previously (13). Rabbit aortic smooth
muscle cells (passage 3) were cultured in 36-well plates until confluent
and were treated in duplicate with control medium, or in medium con-
taining IL-la (10 ng/ml), TNF-a (10 ng/ml), IFN-y (1,000 U/ml), or
phorbol ester (TPA, 100 nm) for 24 h. All lipoproteins used in these
assays were prepared by methods previously detailed (37). Iodination
of AcLDL was accomplished by a modified iodine monochloride reac-
tion (38).
Results
Characterization ofthe goatanti-rabbit ScR antibody. To char-
acterize the specificity of the goat anti-rabbit ScR antibody
used in this study, Western blotting of a variety of wild-type
and mutant ScRproteins was performed (Fig. 1). The goat anti-
sera recognized ScR proteins in COS cells transfected with
wild-type rabbit type H ScR cDNAs, regardless ofthe presence
or absence of a carboxy-terminal rhodopsin epitope tag. The
monoclonal antibody (ID4) to the epitope tag bound those pro-
teins whichcontained theepitope tagbut notthose which lacked
it (data not shown). The bovine type II ScR was not detected
with the anti-serum despite the fact that the bovine receptor
only differs from the rabbit receptor at 2 positions of the 17
residues present in the hapten. The bovine ScR was readily
immunoprecipitated from COS cell lysates with a rabbit anti-
bovine ScR antibody (data not shown), indicating that the bo-
vine receptor was present in the COS cell lysates that were not
recognizedby the goat anti-rabbit ScRantibody on theWestern
blot. Rabbit ScR/human IgG fusion proteins, with or without
the epitope tags, also failed to be detected by the goat anti-
serum. These fusion proteins, which have the NH2-terminal and
transmembrane domains ofthe ScR deleted so that they can be
secreted fromCOS cells, are missing thecytoplasmic sequences
used to generate the anti-serum. The failure to detect these
proteins in combination with the lack of binding of the anti-
serum to the lysate of bovine ScR or mock-transfected COS
cells, established the specificity of the anti-serum for the rabbit
ScR NH2-terminal sequences.
ScR expression by vascular cells in hypercholesterolemic
rabbits after balloon injury. We performed immunocytochemi-
cal studies to characterize ScR protein expression by vascular
cells in aortas from hypercholesterolemic rabbits 10 d after
balloon injury. Wechose to use acombination ofanatherogenic
diet andballoon injury so that we could obtainrelatively fibrous
(smooth muscle-rich) atheromatous lesions in a relatively short
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Figure 1. Demonstration of the specificity of goat anti-serum for the
rabbit ScR by Western blot. Rabbit and bovine scavenger receptor
cDNAs with or without a rhodopsin epitope tag, as well as pCDNA-1
without any insert (mock transfection) were transfected into COS cells.
Lysates oftransfected COS cells were subjected to Western blotting as
described in Methods. Two rabbit ScR/human fusion proteins lacking
the ScR sequences used to raise the goat anti-sera, one with and one
without the epitope tag, were also immunoblotted on the same gel with
the lysates. The blot was labeled from left to the right as follows: Bovine
SR, lysate of COS cells transfected with bovine ScR cDNA; Rabbit SR
epi w/o NT, rabbit ScR/human fusion protein with epitope tag but no
NH2-terminal sequences; Rabbit SR w epi (2X), lysate of COS cells
transfected with rabbit ScR cDNA with the epitope tag (2X amount of
protein loaded compared to 1X samples); Rabbit SR w epi (IX), lysate
of COS cells transfected with rabbit ScR cDNA with the epitope tag;
RabbitSR wt (2X), lysate of COS cells transfected with wild type rabbit
ScR cDNA without the epitope tag; Rabbit SR wt (1X), lysate of COS
cells transfected with wild type rabbit ScR cDNA without the epitope
tag; Rabbit SR wt w/o NT, rabbit ScR/human fusion protein without the
epitope tag and NH2-terminal sequences; Mock-transfected, lysate of
COS cells transfected with pCDNA-l without any insert.
period of time. Fig. 2 shows representative staining patterns of
ScRs and identification markers for smooth muscle cells and
macrophages in serial sections obtained from the balloon-in-
jured aorta of a hypercholesterolemic rabbit. Many cells in the
intimal lesions, unlike medial cells, reacted with the anti-rabbit
ScR antibody (Fig. 2 B), while the same concentration of non-
immune goat serum did not yield any specific staining in the
adjacent serial section (Fig. 2 A). Staining with the smooth
muscle cell identification marker HHF-35 revealed that a sig-
nificant portion of intimal smooth muscle cells were located in
areas where most ScR expressing cells were present (Fig. 2 C,
arrows). Staining for the macrophage marker RAM-II showed
abundant intimal macrophages inregions both with and without
ScR expression, suggesting that some, but not all, intimal mac-
rophages also express ScRs (Fig. 2D). Athighermagnification,
many ScR- expressing cells are spindle-shaped, consistent with
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Figure 2. Immunoperoxidase staining for ScR expression and cell type identification markers in serial sections from the balloon-injured aorta of a
hypercholesterolemic rabbit. (A) Non- immune goat serum yielded no specific staining. XlOO. (B) Goat anti-ScR antibody detected ScR expression
by intimal cells. XlOO. (C) Staining for a-actin by mAb HHF35 revealed that many smooth muscle cells colocalized spatially with ScR-positive
cells (arrows in B and C). XI00. (D) Staining with macrophage marker RAM-il showed abundant intimal macrophages in areas with or without
ScR expression, X100. (E and F) Higher power view of arrow-denoted regions in B and C showed that staining for a-actin and ScR colocalized
in similar areas and that most ScR expressing cells are spindle shaped, consistent with the morphology of intimal smooth muscle cells. X400.
the morphology of intimal smooth muscle cells (Fig. 2, E and
F). The typical smooth muscle cell morphology of some ScR
positive cells and the colocalization of the a-actin and ScR
expression in adjacent serial sections suggested that smooth
muscle cells might comprise a significant fraction ofthe intimal
ScR- expressing cells in the lesions of balloon-injured aortas
from hypercholesterolemic rabbits. Sections from the other four
rabbits in this group revealed similar staining patterns for each
antibody.
To verify the origin of the ScR expressing cells, we per-
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Figure 3. Single and double immunostaining demonstrating that ScRs are expressed by both intimal smooth muscle cells and macrophages in the
balloon-injured areas of the aorta from a hypercholesterolemic rabbit. AD show single immunoperoxidase staining for ScR, a-actin, macrophages,
and T cells respectively in serial sections. X200. (E) Double immunostaining (red, peroxidase staining for a-actin; blue, alkaline phosphatase
staining for ScR) identified many ScR-expressing intimal smooth muscle cells (mixed red and blue) as well as ScR-expressing macrophages (blue
staining only). X200. (F) Higher power view of an area in the double staining section shows the detection of some ScR expressing smooth muscle
cells (spindle-shaped cells with two color staining) and ScR-expressing macrophages (round shaped foam cells with blue staining only). Xl,OOO.
formed double-immunostaining on six specimens from three sections from the balloon injured aorta of a hypercholesterol-
rabbits in the hypercholesterolemic plus balloon injury group emic rabbit. As in Fig. 2, many ScRexpressing cells are present
(two sections from each animal). Fig. 3, A-D shows single in areas where intimal smooth muscle cells are abundant (i.e.,
immunoperoxidase staining for ScRs, a-actin, and macro- areas just below the lumenal surface, A and B). Macrophages
phages, as well as T cells in similar regions of serial cross are detected throughout the entire intimal lesion (C) while T
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3, E and F) demonstrates that many intimal cells express both
a-actin (red staining) and the ScR (blue staining), identifying
these cells as smooth muscle cells that express ScRs. Double
staining also revealed that some ScR positive cells are appar-
ently macrophages (cells that only have blue staining for ScR)
as judged by their morphology (round shaped foam cells) and
their nonreactivity with the anti a-actin antibody. Staining of
serial sections from the other two rabbits showed similar pat-
terns.
ScR expression in non-injured aortas ofhypercholesterol-
emic rabbits. We also performed immunohistochemical studies
on serial sections of non-injured areas in the aortas (ascending
aortas) from all five hypercholesterolemic rabbits. Staining for
a-actin (Fig. 4 B) and macrophages (Fig. 4 C) revealed that a
rather thin layer of smooth muscle cells is present predomi-
nantly in the upperregion ofintimal lesions while macrophages
are distributed across the entire lesion. Both single staining for
ScRs (Fig. 4 A) and double staining (Fig. 4 E) for ScRs (blue)
and smooth muscle cells (red) showed that most ScRexpressing
cells were located toward the bottom layer ofthe intimal lesion
where macrophages were abundant and smooth muscle cells
were rarely detected by a-actin staining. A higher power view
ofan areatowards thebottomofthe intimal lesion in the double-
stained section (Fig. 4 F) reveals that a few cells expressed
both ScRs and a-actin butmostScR-expressing cells (blueonly)
are apparently macrophages as judged by their morphology
(round shaped foam cells) and nonreactivity with a-actin. T
cells are occasionally detected within the intimal lesions (Fig.
4 D). No obvious differences in the number or distribution
pattern of T cells were observed in the intimal lesions of aortas
taken from injured versus non-injured hypercholesterolemic
rabbits.
ScR expression in balloon-injured aortas ofnormocholes-
terolemic rabbits. Fig. 5 shows representative stainings ofserial
sections obtained from balloon-injured aortas (10 d after injury)
of normocholesterolemic rabbits. As with the staining patterns
seen in hypercholesterolemic rabbits, non-immune goat anti-
serum yielded no specific staining (Fig. 5 A). While some cells
in the neointimal lesions expressed the ScR, there appeared to
be fewer ScR positive cells in the normocholesterolemic rabbits
than in the hypercholesterolemic animals (Fig. 5 B, and see
Figs. 2 B, 3 A, and 4 A). Lesions produced by balloon injury
in normocholesterolemic rabbits contained more smooth muscle
cells and fewer macrophages than in the hypercholesterolemic
rabbits (Fig. 5, C-D, and see Figs. 2-4). At higher magnifica-
tion, most ScR-expressing cells have the typical spindle shape
of smooth muscle cells (Fig. 5 E), distinct from the shape of
macrophages (round cells with large nuclei; Fig. 5 F). Sparsely
distributed T cells can also be detected in the neointimal lesions
in a pattern similar to that seen in the hypercholesterolemic
rabbits (data not shown). Non-injured areas of aortas (thoracic
aortas) from normocholesterolemic rabbits had no intimal le-
sions or ScR expression (data not shown). Sections from the
other four rabbits in this group showed similar results.
Cytokine-inducible ScR expression by cultured rabbitaortic
smooth muscle cells in vitro. To explore potential mechanisms
that could account for smooth muscle cell ScR expression in
vivo, we investigated the induction ofScR expression in smooth
muscle cells in vitro by cytokines relevant to atherogenesis.
Rabbit aortic smooth muscle cells were treated with IL-la,
TNF-a, IL-4, lipopolysaccharide (LPS), or IFN-y. Northern
blot analysis (Fig. 6) using total RNA isolated from these cells
showed a low level ofScR mRNA expression underbasal tissue
culture conditions. Treatment of the smooth muscle cells with
TNF-a (10 ng/ml) and IFN-y (1,000 U/ml) for 18 h increased
the expression of ScR mRNA (5.6-fold increase by TNF-a and
2.9-fold increase by IFN-y, as measured by densitometry)
whereas IL-1, IL-4, and LPS did not significantly alter the mes-
sage levels. In RNA isolated from TNF-a- and IFN-y-treated
smooth muscle cells, three bands of 1.8, 2.8, and 3.8 kb were
detected with the cDNA probe as previously shown in phorbol
ester treated rabbit smooth muscle cells (13). Treatment with
TNF-a and IFN-y for 24 h also increased the expression of
ScR protein in rabbit aortic smooth muscle cells as detected
by immunohistochemical staining (Fig. 7, C-F). These cells
expressed very little ScR protein under basal conditions, while
they did express a-actin in a pattern characteristic of cultured
smooth muscle cells (Fig. 7, A and B).
Cytokine-inducible AcLDL degradation activity. We further
assessed the functional consequences of cytokine-induced ScR
expression by studying the binding and degradation of AcLDL
in smooth muscle cells treated with IL-la, TNF-a, IFN-y, or
phorbol esters (TPA, Fig. 8). Under basal tissue culture condi-
tions, smooth muscle cells have a low level ofAcLDL degrada-
tion activity that did not change significantly after treatment
with IL-1. However, treatment with TNF-a or IFN-y increased
the AcLDL degradation activity to a similar (in the case ofIFN-
y treatment) or even higher (in the case of TNF-a treatment)
level than that seen with phorbol ester-stimulated rabbit smooth
muscle cells. Competition experiments showed that the AcLDL
degradation activity induced by TNF-a and IFN-y was ScR
mediated, as unlabeled AcLDL, but not native LDL, blocked
this process.
Discussion
During atherogenesis, certain subpopulations of smooth muscle
cells proliferate and/or undergo morphological and functional
modulation (19, 20). Such phenotypically altered smooth mus-
cle cells exhibit features not shared by normal medial smooth
muscle cells (39). Pitas et al. (27, 40) have shown in vitro that
rabbit fibroblasts and smooth muscle cells inducibly express
macrophage ScRs and that the enhanced ScR activity in these
cells can also result in lipid accumulation and foam cell forma-
tion in culture. Bickel and Freeman (13) used phorbol ester
treated rabbit smooth muscle cells to clone cDNAs encoding
type I and type II ScRs and found that they represented the
rabbit homologues ofthe macrophage ScR. In addition, Jaakola
and Nikkari (41) have demonstrated that a fluorescently sorted
population of rabbit smooth muscle cells, isolated from the
aortas of cholesterol-fed rabbits, varied dramatically with re-
spect to ScR activity. These studies suggested that ScRmediated
uptake of modified LDL may contribute to the generation of
foam cells from smooth muscle cells that reside within athero-
sclerotic lesions.
We used balloon injury in this study because this treatment
produces intimal lesions richer in smooth muscle cells than does
the consumption ofan atherogenic diet alone. The more fibrous
lesions produced by balloon injury resemble human atheroma
more closely than the macrophage-rich lesions observed in unin-
jured arteries of hypercholesterolemic rabbits. Only a few
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Figure 4. Single and double immunostaining of serial sections from the non-injured area (ascending aorta) of a hypercholesterolemic rabbit.
Immunoperoxidase stainings shows that ScRs are located mainly at the bottom layer of the intimal lesion (A) where macrophages were abundant
(C) and smooth muscle cells were rarely detected by a-actin staining (B). X1OO. T cells were detected spread sparsely throughout the intimal lesion
(D). X1OO. Double staining (E, X1OO; and F, X200) for ScR (blue) and smooth muscle cells (red) showed a few ScR expressing smooth muscle
cells (mixed staining ofblue and red) and abundant ScR expressing macrophages (judged by their morphology and the non-reactivity with a-actin,
i.e., cells with blue staining only). Arrow in F indicates internal elastic lamina.
smooth muscle cells, in the intimal lesions produced by balloon
injury alone, expressed ScRs. However, many smooth muscle
cells expressed the ScR if a hypercholesterolemic diet was em-
ployed, both in the injured and non-injured aortic intima. A
subpopulation of ScR-expressing macrophages can also be de-
tected in both injured and non-injured aortas ofhypercholester-
olemic rabbits, while not many such cells are seen in the injury-
induced neointimal lesions of normocholesterolemic rabbits.
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Figure 5. Immunoperoxidase staining for ScR expression and cell type identification markers in serial sections from the balloon-injured aorta of a
normocholesterolemic rabbit. (A) Non- immune goat serum yielded no specific staining. X100. (B) Antibody against ScR stained positively a few
cells in the neointimal lesion. X100. (C) Staining with a-actin showed the presence of abundant smooth muscle cells in the neointima. X1OO. (D)
Antibody RAM- 11 detected some macrophages in the neointima. X100. (E and F) Higher power view of stainings for ScR and macrophages located
in the arrow denoted regions of B and D. Most ScR expressing cells have the typical spindle shape of smooth muscle cells (E) distinct from the
morphology of macrophages which are round cells with large nuclei (F). X1,OOO in the insert and X400 in the other areas.
The mechanism underlying these differences is unclear, but a
growing body of evidence suggests that hypercholesterolemia
itself can induce changes in gene expression in vascular cells
and that such changes may be required forhigh level expression
of the ScR. As intimal lesions in the aorta of hyperlipidemic
rabbits are rich in activated macrophages and T lymphocytes,
there is sufficient opportunity for exposure of smooth muscle
cells to the wide variety of growth factors and cytokines pro-
duced by these inflammatory cells. Thus, it seems likely that
hyperlipidemia could alter smooth muscle cell gene expression
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Figure 6. Northern analysis using total RNA isolated from cultured
rabbit aortic smooth muscle cells with or without cytokine treatment.
A low level of ScR mRNA was expressed by these cells under basal
tissue culture conditions. Treatment of the cells with the cytokines TNF-
a (10 ng/ml) and IFN--y (1,000 U/ml) for 18 h increased the level of
expression of ScR mRNA whereas IL-1 and LPS treatment did not
significantly alter levels (upperpanel, the ScR probe detects three bands
in rabbit SMC as previously reported) (13). Ethidium bromide staining
of total RNA verifies equivalent RNA loading in each lane (lower
panel).
directly or via paracrine factors secreted by local inflammatory
cells (42, 43). Indeed, our in vitro study revealed increased
expression of ScR mRNA, protein, and AcLDL degradation
activity in cultured aortic smooth muscle cells after treatment
with the cytokines TNF-a and IFN-y, both of which are known
to be secreted by activated leukocytes within atherosclerotic
lesions.
Previous studies have established the inducibility of ScR
expression in both smooth muscle cells and macrophages. Pitas
et al. (27) demonstrated an increase in ScR activity in rabbit
smooth muscle cells preincubated with platelet releasates and
in cells preincubated with phorbol ester or mezerein, a non-
phorbol activator ofprotein kinase C. Other studies have shown
that the expression of ScRs increases when monocytes differen-
tiate into macrophages, or when they are treated with secretion
products from thrombin-stimulated platelets, phorbol esters, or
macrophage colony stimulating factor (M-CSF) (22-24). In
contrast to these effects, Geng and Hansson et al. reported that
recombinant IFN-y or IFN-y-containing lymphocyte culture
media inhibits the expression of ScR mRNA, protein and
AcLDL degradation as well as foam cell formation, in human
monocyte-derived macrophages (25). Similarly, several investi-
gators found that IFN-'y inhibits AcLDL degradation in acti-
vated murine macrophages (26, 44). To our surprise, we found
that in rabbit smooth muscle cells, IFN-,y increased the expres-
sion of both ScR mRNA and protein. The IFN-y induced ScR
expression is accompanied by an increase in AcLDL degrada-
tion activity to a level as high as that seen in phorbol ester-
stimulated cells. These apparently divergent transcriptional re-
sponses of macrophages and smooth muscle cells to the same
cytokine may point to important differences in signal transduc-
tion and/or gene regulation in the two cell types and may ac-
count for the increase in smooth muscle-derived foam cells
noted during the later stages of atherogenesis. However, as we
did not examine the effects of IFN-y on rabbit macrophages, it
is possible thatcytokine-induced ScRexpression may be species
as well as cell-type dependent. The possibility of such species
differences in the expression of ScRs, or in cytokine respon-
siveness, preclude the generalization of our observations in rab-
bit aortic smooth muscle cells to the same cell type in the
human or otherspecies. Further studies comparing thecytokine-
inducibleexpression ofScRs in smooth muscle cells and macro-
phages from both rabbits and humans should clarify our under-
standing of the role of these inflammatory molecules in the
pathogenesis of atherosclerosis.
To date, there has been no evidence to indicate that ScRs
are expressed by smooth muscle cells in human atherosclerotic
lesions. In fact, recent studies have demonstrated that macro-
phages in human atherosclerotic lesions express both type I and
type II ScR receptors without evidence for similar receptor
expression in adjacent intimal smooth muscle cells identified
by an antibody against a-actin (16, 17, 45). These findings
clearly differ from those presented here and could reflect, as
stated above, important differences between the biology of the
rabbit models ofatherosclerosis and thehuman condition. How-
ever, the chronic and complex nature of atherogenesis in hu-
mans imposes limitations on studying the pathogenic role of a
specific molecule (such as the ScR) that in part derive from
the limited source of tissues available (i.e., tissues obtained at
autopsy). Furthermore, markers that are used to identify a spe-
cific cell type may themselves be altered by changes in gene
expression, such as those that appear to take place in the transi-
tion from medial to intimal smooth muscle cell. For instance,
it is well known that asubpopulation ofintimal smooth muscles
cells in atherosclerotic lesions have a reduced expression of a-
actin that might preclude their identification as smooth muscle
cells, if a-actin expression were used as the sole histologic
criterion of identity (46-48). These caveats point out the need
for caution both in extrapolating the results from animal studies
to human atherosclerosis as well in interpreting data based on
human postmortem studies. Investigations to assess further the
expression of ScRs in human intimal smooth muscle cells are
currently underway in our own laboratory.
We demonstrated in this study that IFN-y increases ScR
expression and AcLDLdegradation inrabbitaortic smooth mus-
cle cells. IFN-y can also inhibit smooth muscle cell prolifera-
tion, decrease a-actin and interstitial collagen expression, and
increase the expression of VCAM-1, a mononuclear leukocyte
adhesion molecule, in this cell type (49-51). Taken together,
these observations suggest thatIFN--y, aproduct of activated T
cells, may play an important role in the phenotypic modulation
of smooth muscle cells in atherosclerotic lesions. The possible
involvement of IFN-y in regulation of ScR expression further
highlights the important and complex role of T lymphocytes in
atherosclerotic lesions. Previous studies have revealed that T
lymphocytes reside in atherosclerotic lesions and that many of
these T cells are in a chronically activated state, as evidenced
by their production ofLFN-y (2, 52, 53). Our study confirmed
the presence of T cells in the intimal lesions of both injured
and non-injured aortas from hypercholesterolemic rabbits as
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Figure 7. Immunohistochemical staining for ScR expression by rabbit aortic smooth muscle cells plated on tissue culture slides. (A) Very little ScR
expression can be detected in cells cultured in control medium. X100. (B) a-actin staining reveals a cytoskeletal staining pattern characteristic of
smooth muscle cells. X100. (C) Incubation with medium containing TNF-a (10 ng/ml) for 24 h induced ScR expression in many cells. X100. (D)
High power view ofTNF-a-induced ScR expression. X600. (E) IFN-y (1,000 U/ml, 24 h)-induced ScR expression in cultured rabbit aortic smooth
muscle cells. X100. (F) High power view of IFN-y induced ScR expression. X600.
well as in the injury-induced lesions of normocholesterolemic
animals. Although there appeared to be more T cells in areas
of high ScR expression by intimal smooth muscle cells (Fig. 3
D and 4 D), the sparse distribution pattern and paucity of T
cells in the lesions do not permit us to draw conclusions on the
spatial correlation ofT cell and ScR expression or to make any
meaningful quantitative conclusions as to differing numbers of
T cells in injured and non-injured aortas. Further investigations
will be required to clarify the role of T cells and their cytokine
products in the regulation of ScR expression. Further work will
also berequired to determine ifthe activity ofmacrophage ScRs
is sufficient to account for smooth muscle foam cell formation.
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